Coronary stenting increases risks of subsequent non-cardiac surgery
This article was originally published in Clinica
Executive Summary
Patients implanted with either a drug-eluting or bare-metal stent have an elevated risk of death if they undergo non-cardiac surgery, a trial has shown. They are also at risk of non-fatal cardiac complications, including heart attacks and ischaemia. The dangerous period appears to last for at least two years after stenting.
You may also be interested in...
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.